Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.
Description
We facilitate the transition to value-based healthcare by evaluating various treatments, medications, processes, and costs, which aids hospitals, life sciences firms, and payers in pinpointing the most effective treatment strategies for optimal patient results. Our CRCA™ P&T platform equips Pharmacy and Therapeutics committees to implement data-driven enhancements in key quality indicators, including metrics like average length of stay (ALOS) and 30-day readmissions. The innovative POP-BUILDER Rx™ solution offers comparative evaluations among chosen cohorts against CRCA’s extensive real-world data index, which encompasses over 140 million longitudinal patient records. Additionally, our drug remittance dashboard provides an in-depth analysis and reporting of drug remittance information across different payer categories, focusing on high-cost medications at the National Drug Code (NDC) level. Furthermore, we assist hospital finance teams in effectively tracking and enhancing service line costs and profitability, productivity, and revenue cycle performance through our insightful analytics, detailed reporting, and the expertise of our Agilum Healthcare Intelligence team. This comprehensive approach ensures that healthcare providers can make informed decisions that positively impact both operational efficiency and patient care.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
AarogyaAI
Country
India
Website
aarogya.ai/
Vendor Details
Company Name
Agilum
Founded
2005
Country
United States
Website
agilum.com